Table 2.
Toxicity and adverse effects in BCG Danish 1331 and BCG Moscow-I strain groups.
| Variable | Danish 1331 strain (n=68) | Moscow-I strain (n=46) | p-Value |
|---|---|---|---|
| Side effect, n (%) | |||
| Nil to mild | 35 (51.5) | 15 (32.6) | 0.046 |
| Moderate to severe | 33 (48.5) | 31 (67.4) | |
| BCG discontinuation/dose reduction, n (%) | |||
| No | 51 (75) | 26 (56.5) | 0.039 |
| Yes | 17 (25) | 20 (43.5) | |
| Requiring antitubercular therapy, n (%) | |||
| No | 63 (92.6) | 37 (80.4) | 0.051 |
| Yes | 5 (7.4) | 9 (19.6) | |
| Requiring cystectomy for BCG side effect, n (%) | |||
| No | 66 (97.1) | 41 (89.1) | 0.093 |
| Yes | 2 (2.9) | 5 (10.9) | |
BCG, bacillus Calmette-Guerin.